| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.697 | 0.008 | 0.697 | Aldehyde oxidase inhibitor | |||
| 0.711 | 0.023 | 0.711 | Caspase 9 stimulant | 0.677 0.027 CID_154699960 | ||
| 0.669 | 0.01 | 0.832 | Cholesterol antagonist | 0.832 0.004 CID_154699960 | CID_154699960 | |
| 0.633 | 0.005 | 0.633 | Superoxide dismutase inhibitor | |||
| 0.59 | 0.005 | 0.59 | Anesthetic general | 0.569 0.005 CID_154699960 | ||
| 0.589 | 0.015 | 0.589 | 5 Hydroxytryptamine release stimulant | 0.403 0.045 CID_154699960 | ||
| 0.574 | 0.005 | 0.574 | Peroxidase inhibitor | |||
| 0.57 | 0.011 | 0.57 | GABA C receptor rho-3 antagonist | |||
| 0.609 | 0.051 | 0.848 | Antiinflammatory | 0.848 0.009 CID_154699960 | CID_154699960 | |
| 0.561 | 0.014 | 0.691 | Histamine release inhibitor | 0.691 0.005 CID_154699960 | CID_154699960 | |
| 0.523 | 0.011 | 0.524 | Hypolipemic | 0.524 0.011 CID_154699960 | CID_154699960 | |
| 0.48 | 0.004 | 0.48 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.484 | 0.022 | 0.713 | Antioxidant | 0.713 0.005 CID_154699960 | CID_154699960 | |
| 0.493 | 0.035 | 0.563 | 5 Hydroxytryptamine release inhibitor | 0.563 0.017 CID_154699960 | CID_154699960 | |
| 0.446 | 0.004 | 0.446 | Alcohol oxidase inhibitor | 0.051 0.044 CID_154699960 | ||
| 0.446 | 0.012 | 0.446 | Calcium channel activator | 0.249 0.149 CID_154699960 | ||
| 0.44 | 0.009 | 0.44 | Sodium/bile acid cotransporter inhibitor | 0.36 0.034 CID_154699960 | ||
| 0.451 | 0.022 | 0.644 | Free radical scavenger | 0.644 0.007 CID_154699960 | CID_154699960 | |
| 0.47 | 0.041 | 0.47 | Calcium channel L-type activator | |||
| 0.437 | 0.009 | 0.437 | 5 Hydroxytryptamine uptake stimulant | 0.19 0.174 CID_154699960 | ||
| 0.427 | 0.008 | 0.659 | Alpha-N-acetylglucosaminidase inhibitor | 0.659 0.003 CID_154699960 | CID_154699960 | |
| 0.418 | 0.004 | 0.418 | TRPA1 agonist | 0.209 0.009 CID_154699960 | ||
| 0.463 | 0.05 | 0.758 | Transcription factor NF kappa B inhibitor | 0.758 0.016 CID_154699960 | CID_154699960 | |
| 0.448 | 0.041 | 0.448 | Vasodilator, peripheral | 0.426 0.047 CID_154699960 | ||
| 0.428 | 0.033 | 0.428 | 12-Lipoxygenase inhibitor | |||
| 0.418 | 0.025 | 0.752 | Hypoglycemic | 0.752 0.004 CID_154699960 | CID_154699960 | |
| 0.401 | 0.01 | 0.401 | Phospholipase C inhibitor | 0.301 0.018 CID_154699960 | ||
| 0.393 | 0.012 | 0.677 | Monophenol monooxygenase inhibitor | 0.677 0.004 CID_154699960 | CID_154699960 | |
| 0.461 | 0.087 | 0.656 | Apoptosis agonist | 0.656 0.038 CID_154699960 | CID_154699960 | |
| 0.404 | 0.034 | 0.62 | Vasodilator, coronary | 0.62 0.007 CID_154699960 | CID_154699960 | |
| 0.385 | 0.02 | 0.385 | RNA-directed DNA polymerase inhibitor | 0.308 0.03 CID_154699960 | ||
| 0.368 | 0.005 | 0.368 | Estrogen antagonist | 0.104 0.088 CID_154699960 | ||
| 0.369 | 0.007 | 0.38 | Neurotrophic factor enhancer | 0.38 0.007 CID_154699960 | CID_154699960 | |
| 0.418 | 0.056 | 0.573 | Immunosuppressant | 0.573 0.017 CID_154699960 | CID_154699960 | |
| 0.398 | 0.038 | 0.398 | Lipoxygenase inhibitor | |||
| 0.372 | 0.014 | 0.561 | Melanin inhibitor | 0.561 0.005 CID_154699960 | CID_154699960 | |
| 0.367 | 0.01 | 0.521 | Protein kinase stimulant | 0.521 0.004 CID_154699960 | CID_154699960 | |
| 0.383 | 0.027 | 0.383 | Amyloid beta aggregation inhibitor | 0.196 0.08 CID_154699960 | ||
| 0.359 | 0.005 | 0.359 | Estrogen receptor beta antagonist | |||
| 0.426 | 0.077 | 0.853 | Cyclophilin D inhibitor | 0.853 0.005 CID_154699960 | CID_154699960 | |
| 0.365 | 0.018 | 0.623 | Non-steroidal antiinflammatory agent | 0.623 0.004 CID_154699960 | CID_154699960 | |
| 0.354 | 0.012 | 0.354 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.288 0.027 CID_154699960 | ||
| 0.382 | 0.044 | 0.505 | Spasmolytic | 0.505 0.022 CID_154699960 | CID_154699960 | |
| 0.341 | 0.009 | 0.341 | Heat shock protein 90 alpha antagonist | |||
| 0.335 | 0.006 | 0.335 | Heat shock protein 90 antagonist | 0.133 0.094 CID_154699960 | ||
| 0.396 | 0.076 | 0.396 | 15-Lipoxygenase inhibitor | |||
| 0.318 | 0.004 | 0.318 | Vanilloid agonist | 0.111 0.024 CID_154699960 | ||
| 0.31 | 0.005 | 0.31 | Estrogen agonist | 0.093 0.019 CID_154699960 | ||
| 0.377 | 0.073 | 0.377 | Calpain 2 inhibitor | |||
| 0.347 | 0.051 | 0.347 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.317 | 0.023 | 0.317 | Gastrin inhibitor | 0.286 0.043 CID_154699960 | ||
| 0.297 | 0.004 | 0.297 | Creatine kinase inhibitor | |||
| 0.311 | 0.018 | 0.486 | Interferon gamma antagonist | 0.486 0.007 CID_154699960 | CID_154699960 | |
| 0.34 | 0.05 | 0.484 | Interleukin 2 agonist | 0.484 0.01 CID_154699960 | CID_154699960 | |
| 0.394 | 0.106 | 0.394 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.349 | 0.065 | 0.764 | Antithrombotic | 0.764 0.005 CID_154699960 | CID_154699960 | |
| 0.293 | 0.01 | 0.293 | Cystathionine beta-synthase inhibitor | 0.247 0.015 CID_154699960 | ||
| 0.286 | 0.004 | 0.286 | Prolactin inhibitor | |||
| 0.297 | 0.014 | 0.297 | Cyclooxygenase 1 inhibitor | 0.161 0.051 CID_154699960 | ||
| 0.298 | 0.018 | 0.298 | Amyloid beta precursor protein antagonist | |||
| 0.299 | 0.019 | 0.389 | Lipid peroxidase inhibitor | 0.389 0.01 CID_154699960 | CID_154699960 | |
| 0.324 | 0.045 | 0.427 | Antiamyloidogenic | 0.427 0.025 CID_154699960 | CID_154699960 | |
| 0.291 | 0.012 | 0.291 | Succinate dehydrogenase inhibitor | 0.162 0.091 CID_154699960 | ||
| 0.291 | 0.014 | 0.291 | Nitric-oxide synthase stimulant | 0.289 0.014 CID_154699960 | ||
| 0.316 | 0.04 | 0.47 | Interleukin agonist | 0.47 0.011 CID_154699960 | CID_154699960 | |
| 0.283 | 0.008 | 0.459 | ATPase inhibitor | 0.459 0.003 CID_154699960 | CID_154699960 | |
| 0.278 | 0.005 | 0.278 | Vanilloid 1 agonist | 0.238 0.006 CID_154699960 | ||
| 0.335 | 0.063 | 0.56 | Apoptosis antagonist | 0.56 0.014 CID_154699960 | CID_154699960 | |
| 0.291 | 0.019 | 0.613 | Amylase inhibitor | 0.613 0.004 CID_154699960 | CID_154699960 | |
| 0.326 | 0.054 | 0.361 | Hypoxia-inducible factor 1 alpha inhibitor | 0.361 0.041 CID_154699960 | CID_154699960 | |
| 0.275 | 0.005 | 0.275 | GABA C receptor antagonist | |||
| 0.275 | 0.007 | 0.668 | Cyclooxygenase 3 inhibitor | 0.668 0.002 CID_154699960 | CID_154699960 | |
| 0.275 | 0.011 | 0.275 | GABA C receptor agonist | |||
| 0.265 | 0.002 | 0.265 | Estrogen-related receptor beta agonist | 0.092 0.037 CID_154699960 | ||
| 0.273 | 0.01 | 0.273 | Nav1.1 sodium channel blocker | |||
| 0.268 | 0.006 | 0.268 | Porphobilinogen synthase inhibitor | |||
| 0.306 | 0.046 | 0.306 | Pyruvate kinase inhibitor | |||
| 0.311 | 0.052 | 0.311 | Insulysin inhibitor | |||
| 0.333 | 0.08 | 0.333 | Thyroid hormone antagonist | |||
| 0.262 | 0.01 | 0.276 | Mannose-6-phosphate isomerase inhibitor | 0.276 0.008 CID_154699960 | CID_154699960 | |
| 0.26 | 0.007 | 0.26 | Potassium channel (Ca-activated) activator | |||
| 0.266 | 0.017 | 0.458 | Insulin secretagoues | 0.458 0.005 CID_154699960 | CID_154699960 | |
| 0.252 | 0.005 | 0.252 | Keratolytic | |||
| 0.261 | 0.016 | 0.261 | Aldehyde dehydrogenase inhibitor | 0.219 0.024 CID_154699960 | ||
| 0.259 | 0.015 | 0.259 | Chelator | |||
| 0.255 | 0.011 | 0.255 | Farnesoid X receptor antagonist | |||
| 0.347 | 0.103 | 0.665 | Antibacterial | 0.665 0.012 CID_154699960 | CID_154699960 | |
| 0.245 | 0.007 | 0.47 | Triose-phosphate isomerase inhibitor | 0.47 0.003 CID_154699960 | CID_154699960 | |
| 0.251 | 0.013 | 0.442 | UDP-glucose 4-epimerase inhibitor | 0.442 0.004 CID_154699960 | CID_154699960 | |
| 0.242 | 0.005 | 0.242 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.253 | 0.017 | 0.253 | Cholesterol synthesis inhibitor | 0.181 0.032 CID_154699960 | ||
| 0.239 | 0.003 | 0.239 | GABA B receptor agonist | |||
| 0.241 | 0.008 | 0.241 | Arachidonic acid antagonist | 0.199 0.034 CID_154699960 | ||
| 0.274 | 0.046 | 0.51 | Nitric oxide antagonist | 0.51 0.015 CID_154699960 | CID_154699960 | |
| 0.281 | 0.057 | 0.821 | Angiogenesis stimulant | 0.821 0.004 CID_154699960 | CID_154699960 | |
| 0.246 | 0.022 | 0.246 | Nav1.2 sodium channel blocker | |||
| 0.243 | 0.022 | 0.243 | Neurotensin receptor agonist | |||
| 0.238 | 0.018 | 0.238 | 5-Lipoxygenase inhibitor | |||
| 0.243 | 0.028 | 0.38 | NOS3 expression enhancer | 0.38 0.009 CID_154699960 | CID_154699960 | |
| 0.217 | 0.004 | 0.217 | Purinergic P2X2 antagonist | 0.115 0.023 CID_154699960 | ||
| 0.26 | 0.047 | 0.26 | Neuropeptide Y2 antagonist | |||
| 0.242 | 0.031 | 0.242 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.292 | 0.082 | 0.292 | Streptokinase A inhibitor | |||
| 0.239 | 0.03 | 0.239 | Histone acetyltransferase inhibitor | |||
| 0.213 | 0.004 | 0.213 | Acetyl-CoA transferase inhibitor | 0.071 0.024 CID_154699960 | ||
| 0.298 | 0.089 | 0.298 | Thyroid hormone beta antagonist | |||
| 0.212 | 0.005 | 0.212 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.274 | 0.068 | 0.303 | DNA damaging | 0.303 0.056 CID_154699960 | CID_154699960 | |
| 0.263 | 0.058 | 0.416 | Cyclic AMP phosphodiesterase inhibitor | 0.416 0.014 CID_154699960 | CID_154699960 | |
| 0.222 | 0.018 | 0.222 | Ferrochelatase inhibitor | |||
| 0.213 | 0.011 | 0.225 | Mucolytic | 0.225 0.009 CID_154699960 | CID_154699960 | |
| 0.208 | 0.008 | 0.208 | Estrogen receptor alpha antagonist | |||
| 0.208 | 0.007 | 0.208 | Macrophage migration inhibitory factor inhibitor | |||
| 0.239 | 0.04 | 0.239 | Mcl-1 antagonist | |||
| 0.223 | 0.024 | 0.393 | Hexokinase inhibitor | 0.393 0.004 CID_154699960 | CID_154699960 | |
| 0.203 | 0.004 | 0.203 | Glycine receptor agonist | 0.178 0.005 CID_154699960 | ||
| 0.204 | 0.006 | 0.204 | DOPA decarboxylase inhibitor | |||
| 0.218 | 0.021 | 0.218 | GABA C receptor rho-2 antagonist | |||
| 0.223 | 0.026 | 0.223 | Anesthetic local | |||
| 0.258 | 0.062 | 0.416 | DNA synthesis inhibitor | 0.416 0.02 CID_154699960 | CID_154699960 | |
| 0.241 | 0.046 | 0.563 | Hepatoprotectant | 0.563 0.005 CID_154699960 | CID_154699960 | |
| 0.204 | 0.009 | 0.204 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.218 | 0.028 | 0.218 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.208 | 0.019 | 0.545 | Expectorant | 0.545 0.003 CID_154699960 | CID_154699960 | |
| 0.264 | 0.077 | 0.264 | Transcription factor STAT inhibitor | |||
| 0.2 | 0.013 | 0.2 | Adenylate cyclase stimulant | 0.144 0.073 CID_154699960 | ||
| 0.232 | 0.046 | 0.232 | Insulin sensitizer | 0.228 0.049 CID_154699960 | ||
| 0.193 | 0.007 | 0.193 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.187 | 0.005 | 0.187 | Estrogen receptor beta agonist | 0.028 0.024 CID_154699960 | ||
| 0.195 | 0.012 | 0.195 | Pregnane X receptor agonist | |||
| 0.185 | 0.004 | 0.185 | Heat shock protein 90 beta antagonist | |||
| 0.224 | 0.043 | 0.224 | Lipocortins synthesis antagonist | 0.188 0.065 CID_154699960 | ||
| 0.185 | 0.005 | 0.185 | Ca2+-transporting ATPase inhibitor | 0.179 0.007 CID_154699960 | ||
| 0.229 | 0.049 | 0.229 | I kappa B kinase epsilon inhibitor | |||
| 0.215 | 0.036 | 0.215 | Cyclooxygenase inhibitor | 0.137 0.082 CID_154699960 | ||
| 0.192 | 0.015 | 0.192 | Interleukin 8 antagonist | |||
| 0.181 | 0.005 | 0.201 | Glutamate release inhibitor | 0.201 0.005 CID_154699960 | CID_154699960 | |
| 0.241 | 0.065 | 0.241 | Interleukin antagonist | |||
| 0.198 | 0.023 | 0.198 | CF transmembrane conductance regulator agonist | 0.144 0.086 CID_154699960 | ||
| 0.191 | 0.017 | 0.28 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.28 0.007 CID_154699960 | CID_154699960 | |
| 0.207 | 0.032 | 0.207 | NADPH oxidase inhibitor | 0.141 0.061 CID_154699960 | ||
| 0.19 | 0.017 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.243 | 0.072 | 0.243 | Calpain inhibitor | |||
| 0.193 | 0.022 | 0.193 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.185 | 0.015 | 0.185 | Histidine decarboxylase inhibitor | |||
| 0.177 | 0.008 | 0.177 | Potassium channel large-conductance Ca-activated activator | |||
| 0.174 | 0.006 | 0.174 | Ornithine decarboxylase inhibitor | 0.144 0.013 CID_154699960 | ||
| 0.194 | 0.026 | 0.194 | Toll-Like receptor 2 antagonist | |||
| 0.207 | 0.039 | 0.207 | Phospholipase A2 inhibitor | 0.181 0.054 CID_154699960 | ||
| 0.183 | 0.018 | 0.507 | Mediator release inhibitor | 0.507 0.004 CID_154699960 | CID_154699960 | |
| 0.169 | 0.005 | 0.169 | GABA aminotransferase inhibitor | 0.15 0.008 CID_154699960 | ||
| 0.168 | 0.005 | 0.168 | Estrogen receptor alpha agonist | |||
| 0.173 | 0.009 | 0.173 | Glutamate decarboxylase inhibitor | |||
| 0.169 | 0.007 | 0.169 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.201 | 0.04 | 0.296 | Interleukin 6 antagonist | 0.296 0.015 CID_154699960 | CID_154699960 | |
| 0.206 | 0.045 | 0.206 | Antipruritic | |||
| 0.169 | 0.01 | 0.169 | CDC25A inhibitor | 0.066 0.065 CID_154699960 | ||
| 0.172 | 0.016 | 0.178 | Heat shock protein 70 antagonist | 0.178 0.013 CID_154699960 | CID_154699960 | |
| 0.17 | 0.014 | 0.341 | NADH dehydrogenase inhibitor | 0.341 0.006 CID_154699960 | CID_154699960 | |
| 0.207 | 0.052 | 0.207 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.242 | 0.09 | 0.242 | Transcription factor STAT3 inhibitor | |||
| 0.172 | 0.022 | 0.172 | Carbonic anhydrase III inhibitor | 0.094 0.069 CID_154699960 | ||
| 0.173 | 0.024 | 0.173 | Carbonic anhydrase XV inhibitor | |||
| 0.197 | 0.048 | 0.197 | Protein-tyrosine phosphatase inhibitor | 0.178 0.057 CID_154699960 | ||
| 0.185 | 0.037 | 0.376 | Cell wall synthesis inhibitor | 0.376 0.007 CID_154699960 | CID_154699960 | |
| 0.234 | 0.086 | 0.234 | Aryl hydrocarbon receptor agonist | |||
| 0.169 | 0.021 | 0.251 | Photosensitizer | 0.251 0.006 CID_154699960 | CID_154699960 | |
| 0.178 | 0.031 | 0.178 | Adenylate cyclase inhibitor | 0.117 0.07 CID_154699960 | ||
| 0.21 | 0.064 | 0.31 | DNA methyltransferase I inhibitor | 0.31 0.023 CID_154699960 | CID_154699960 | |
| 0.18 | 0.035 | 0.185 | Protein-tyrosine phosphatase 1B inhibitor | 0.185 0.033 CID_154699960 | CID_154699960 | |
| 0.254 | 0.109 | 0.316 | Caspase 3 stimulant | 0.316 0.071 CID_154699960 | CID_154699960 | |
| 0.216 | 0.072 | 0.216 | MAP kinase kinase 2 inhibitor | |||
| 0.165 | 0.022 | 0.165 | Adenylate kinase inhibitor | 0.134 0.034 CID_154699960 | ||
| 0.15 | 0.008 | 0.15 | Glycine transporter 2 inhibitor | |||
| 0.156 | 0.015 | 0.156 | Anabolic | 0.093 0.072 CID_154699960 | ||
| 0.169 | 0.03 | 0.169 | Aminopeptidase B inhibitor | |||
| 0.288 | 0.151 | 0.288 | Analgesic | |||
| 0.209 | 0.073 | 0.326 | DNA methylase inhibitor | 0.326 0.021 CID_154699960 | CID_154699960 | |
| 0.144 | 0.008 | 0.144 | Bile acid receptor antagonist | 0.105 0.04 CID_154699960 | ||
| 0.139 | 0.003 | 0.139 | Dopamine D5 agonist | |||
| 0.231 | 0.096 | 0.231 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.159 | 0.026 | 0.159 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.154 | 0.021 | 0.154 | Urease inhibitor | |||
| 0.15 | 0.017 | 0.15 | ABCA1 expression enhancer | |||
| 0.167 | 0.036 | 0.167 | Interleukin 4 antagonist | 0.15 0.05 CID_154699960 | ||
| 0.151 | 0.021 | 0.151 | GABA C receptor rho-1 antagonist | |||
| 0.14 | 0.011 | 0.14 | TRPA1 antagonist | |||
| 0.172 | 0.042 | 0.172 | Toll-Like receptor antagonist | |||
| 0.233 | 0.104 | 0.521 | Immunostimulant | 0.521 0.026 CID_154699960 | CID_154699960 | |
| 0.133 | 0.005 | 0.133 | CC chemokine 5 receptor agonist | |||
| 0.166 | 0.038 | 0.166 | Nav1.6 sodium channel blocker | |||
| 0.158 | 0.031 | 0.158 | Nav1.4 sodium channel blocker | |||
| 0.136 | 0.009 | 0.136 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.134 0.009 CID_154699960 | ||
| 0.144 | 0.019 | 0.26 | Phosphofructokinase-1 inhibitor | 0.26 0.007 CID_154699960 | CID_154699960 | |
| 0.133 | 0.009 | 0.133 | D-Ala-D-Ala ligase inhibitor | |||
| 0.202 | 0.079 | 0.21 | Psychostimulant | 0.21 0.075 CID_154699960 | CID_154699960 | |
| 0.148 | 0.025 | 0.148 | Transcription factor STAT6 inhibitor | |||
| 0.156 | 0.033 | 0.156 | GABA receptor agonist | |||
| 0.156 | 0.035 | 0.21 | Microtubule formation inhibitor | 0.21 0.018 CID_154699960 | CID_154699960 | |
| 0.157 | 0.036 | 0.181 | Beta amyloid protein antagonist | 0.181 0.024 CID_154699960 | CID_154699960 | |
| 0.152 | 0.032 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.168 | 0.049 | 0.174 | Alkaline phosphatase inhibitor | 0.174 0.046 CID_154699960 | CID_154699960 | |
| 0.135 | 0.016 | 0.135 | Glutathione S-transferase inhibitor | 0.079 0.062 CID_154699960 | ||
| 0.129 | 0.011 | 0.129 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.159 | 0.041 | 0.159 | Proteasome inhibitor | |||
| 0.161 | 0.044 | 0.18 | DNA polymerase I inhibitor | 0.18 0.035 CID_154699960 | CID_154699960 | |
| 0.123 | 0.009 | 0.123 | NMDA 2A receptor antagonist | |||
| 0.134 | 0.021 | 0.134 | Toll-Like receptor 3 antagonist | |||
| 0.142 | 0.029 | 0.386 | Beta glucuronidase inhibitor | 0.386 0.004 CID_154699960 | CID_154699960 | |
| 0.141 | 0.028 | 0.141 | Catalase inhibitor | |||
| 0.163 | 0.05 | 0.163 | Bone formation stimulant | 0.127 0.079 CID_154699960 | ||
| 0.133 | 0.02 | 0.133 | NMDA 2 receptor antagonist | |||
| 0.117 | 0.004 | 0.117 | Retinoid X alpha receptor agonist | |||
| 0.12 | 0.007 | 0.12 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.116 | 0.004 | 0.116 | Nicotinic acid receptor agonist | |||
| 0.16 | 0.051 | 0.16 | Neuropeptide Y1 antagonist | |||
| 0.135 | 0.027 | 0.135 | Androgen antagonist | |||
| 0.12 | 0.011 | 0.12 | CDC25B inhibitor | |||
| 0.152 | 0.044 | 0.152 | Antibacterial (Helicobacter pylori) | |||
| 0.134 | 0.026 | 0.134 | Alcohol dehydrogenase inhibitor | 0.106 0.046 CID_154699960 | ||
| 0.122 | 0.016 | 0.122 | Leukotriene synthesis inhibitor | |||
| 0.111 | 0.004 | 0.111 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.124 | 0.018 | 0.124 | Aminopeptidase I inhibitor | |||
| 0.11 | 0.005 | 0.11 | Estrogen-related receptor alpha antagonist | |||
| 0.125 | 0.021 | 0.125 | Glutamate dehydrogenase inhibitor | 0.088 0.038 CID_154699960 | ||
| 0.107 | 0.005 | 0.107 | CXC chemokine 1 receptor antagonist | |||
| 0.12 | 0.018 | 0.12 | Aromatase inhibitor | |||
| 0.105 | 0.005 | 0.105 | Calcium channel P-type blocker | |||
| 0.148 | 0.048 | 0.289 | Alkylator | 0.289 0.013 CID_154699960 | CID_154699960 | |
| 0.111 | 0.012 | 0.111 | Androgen agonist | |||
| 0.111 | 0.013 | 0.111 | NMDA 2C receptor antagonist | |||
| 0.113 | 0.014 | 0.113 | Bombesin 1 receptor agonist | |||
| 0.131 | 0.033 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 CID_154699960 | CID_154699960 | |
| 0.102 | 0.004 | 0.102 | Calcium-sensing receptor antagonist | |||
| 0.106 | 0.009 | 0.106 | MAP kinase kinase 7 inhibitor | |||
| 0.101 | 0.005 | 0.101 | Retinoid X receptor agonist | |||
| 0.11 | 0.014 | 0.11 | Purinergic P2X1 antagonist | 0.055 0.051 CID_154699960 | ||
| 0.126 | 0.03 | 0.126 | MAP kinase kinase 1 inhibitor | |||
| 0.103 | 0.008 | 0.103 | Potassium channel Kv1.3 blocker | |||
| 0.137 | 0.043 | 0.137 | 5 Hydroxytryptamine 3A agonist | |||
| 0.109 | 0.017 | 0.109 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.1 | 0.008 | 0.1 | Sphingosine kinase 2 inhibitor | |||
| 0.115 | 0.023 | 0.144 | ATPase (Vacuolar H+) inhibitor | 0.144 0.009 CID_154699960 | CID_154699960 | |
| 0.269 | 0.176 | 0.527 | Alpha-glucosidase inhibitor | 0.527 0.073 CID_154699960 | CID_154699960 | |
| 0.122 | 0.031 | 0.122 | Protein kinase C zeta inhibitor | |||
| 0.119 | 0.028 | 0.119 | Vanilloid antagonist | |||
| 0.107 | 0.016 | 0.107 | Biliverdin reductase inhibitor | 0.073 0.03 CID_154699960 | ||
| 0.096 | 0.005 | 0.096 | Dihydroorotate oxidase inhibitor | |||
| 0.196 | 0.105 | 0.422 | Peptidyltransferase inhibitor | 0.422 0.005 CID_154699960 | CID_154699960 | |
| 0.095 | 0.005 | 0.095 | Ryanodine receptor antagonist | |||
| 0.15 | 0.06 | 0.15 | MAO inhibitor | |||
| 0.097 | 0.008 | 0.097 | 5 Hydroxytryptamine 7 agonist | |||
| 0.119 | 0.031 | 0.119 | Glutamate (mGluR7) agonist | |||
| 0.118 | 0.03 | 0.118 | Carbonic anhydrase VI inhibitor | |||
| 0.091 | 0.005 | 0.091 | Purinergic P2X4 antagonist | |||
| 0.091 | 0.005 | 0.091 | Cholesterol esterase inhibitor | 0.056 0.022 CID_154699960 | ||
| 0.091 | 0.005 | 0.091 | Liver X receptor alpha agonist | |||
| 0.123 | 0.037 | 0.174 | Uric acid excretion stimulant | 0.174 0.017 CID_154699960 | CID_154699960 | |
| 0.09 | 0.004 | 0.09 | Dopamine beta hydroxylase inhibitor | |||
| 0.104 | 0.018 | 0.104 | Argininosuccinate synthase inhibitor | 0.071 0.029 CID_154699960 | ||
| 0.094 | 0.009 | 0.094 | Heme oxygenase stimulant | 0.064 0.035 CID_154699960 | ||
| 0.116 | 0.031 | 0.12 | Carbonic anhydrase XIII inhibitor | 0.12 0.029 CID_154699960 | CID_154699960 | |
| 0.097 | 0.013 | 0.097 | Glutamate (mGluR7) antagonist | |||
| 0.113 | 0.029 | 0.113 | Adrenaline agonist | |||
| 0.086 | 0.003 | 0.086 | Thyroid hormone agonist | 0.026 0.018 CID_154699960 | ||
| 0.108 | 0.025 | 0.128 | Na+ K+ transporting ATPase inhibitor | 0.128 0.012 CID_154699960 | CID_154699960 | |
| 0.092 | 0.01 | 0.092 | Aconitate hydratase inhibitor | |||
| 0.093 | 0.011 | 0.093 | NMDA receptor subunit 3B antagonist | |||
| 0.138 | 0.056 | 0.138 | Cathepsin H inhibitor | |||
| 0.092 | 0.01 | 0.092 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.125 | 0.044 | 0.38 | AMP-activated protein kinase stimulant | 0.38 0.004 CID_154699960 | CID_154699960 | |
| 0.091 | 0.011 | 0.091 | Cyclin D1 inhibitor | |||
| 0.11 | 0.03 | 0.11 | Cathepsin G inhibitor | |||
| 0.118 | 0.037 | 0.118 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.161 | 0.081 | 0.161 | Catenin beta inhibitor | |||
| 0.107 | 0.027 | 0.158 | Glycine receptor antagonist | 0.158 0.006 CID_154699960 | CID_154699960 | |
| 0.117 | 0.037 | 0.117 | NMDA receptor antagonist | |||
| 0.084 | 0.004 | 0.084 | Alpha 1L adrenoreceptor agonist | |||
| 0.141 | 0.061 | 0.141 | M17 leucyl aminopeptidase inhibitor | |||
| 0.095 | 0.016 | 0.095 | Beta 3 adrenoreceptor antagonist | |||
| 0.102 | 0.025 | 0.102 | HIV-1 integrase (3'-Processing) inhibitor | 0.057 0.05 CID_154699960 | ||
| 0.148 | 0.071 | 0.463 | Hemostatic | 0.463 0.005 CID_154699960 | CID_154699960 | |
| 0.105 | 0.028 | 0.105 | mTOR complex 2 inhibitor | |||
| 0.116 | 0.04 | 0.116 | Electrolyte absorption antagonist | |||
| 0.099 | 0.023 | 0.099 | HIV-1 integrase (Strand Transfer) inhibitor | 0.058 0.043 CID_154699960 | ||
| 0.094 | 0.018 | 0.094 | Acyl-CoA dehydrogenase inhibitor | 0.049 0.043 CID_154699960 | ||
| 0.079 | 0.005 | 0.079 | Geranyltranstransferase inhibitor | |||
| 0.078 | 0.004 | 0.078 | Thyroid hormone alpha antagonist | |||
| 0.093 | 0.02 | 0.093 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.137 | 0.065 | 0.137 | Cyclooxygenase 2 inhibitor | |||
| 0.088 | 0.017 | 0.088 | Glutamate (mGluR6) antagonist | |||
| 0.081 | 0.009 | 0.081 | Squalene epoxidase inhibitor | |||
| 0.11 | 0.039 | 0.132 | Interleukin 12 antagonist | 0.132 0.02 CID_154699960 | CID_154699960 | |
| 0.119 | 0.048 | 0.119 | Electron transport complex I inhibitor | |||
| 0.093 | 0.023 | 0.093 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.117 | 0.047 | 0.184 | Toll-Like receptor 4 antagonist | 0.184 0.009 CID_154699960 | CID_154699960 | |
| 0.164 | 0.096 | 0.18 | P-glycoprotein inhibitor | 0.18 0.08 CID_154699960 | CID_154699960 | |
| 0.077 | 0.009 | 0.077 | Urate transporter 1 inhibitor | |||
| 0.072 | 0.004 | 0.072 | ATP citrate lysase inhibitor | |||
| 0.113 | 0.046 | 0.113 | Folate antagonist | 0.112 0.047 CID_154699960 | ||
| 0.082 | 0.015 | 0.082 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.122 | 0.057 | 0.122 | Caspase 3 inhibitor | |||
| 0.07 | 0.005 | 0.07 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.067 | 0.002 | 0.067 | Estrogen-related receptor gamma antagonist | |||
| 0.082 | 0.018 | 0.082 | MDM2 inhibitor | |||
| 0.092 | 0.027 | 0.092 | Toll-Like receptor 7 antagonist | |||
| 0.106 | 0.042 | 0.147 | Thioredoxin inhibitor | 0.147 0.018 CID_154699960 | CID_154699960 | |
| 0.069 | 0.005 | 0.069 | Liver X receptor beta antagonist | |||
| 0.068 | 0.004 | 0.068 | Retinoid X receptor antagonist | |||
| 0.073 | 0.009 | 0.073 | Immunoglobulin Fc receptor antagonist | |||
| 0.107 | 0.043 | 0.107 | Opioid antagonist | |||
| 0.144 | 0.08 | 0.144 | Acetylcholine M1 receptor antagonist | |||
| 0.069 | 0.006 | 0.069 | Glucagon receptor antagonist | |||
| 0.075 | 0.013 | 0.075 | Beta 2 adrenoreceptor agonist | |||
| 0.08 | 0.017 | 0.08 | Botulinum neurotoxin type A inhibitor | |||
| 0.116 | 0.054 | 0.116 | MAO A inhibitor | |||
| 0.081 | 0.019 | 0.081 | Phosphodiesterase 1C inhibitor | |||
| 0.087 | 0.025 | 0.087 | Phospholipase D inhibitor | |||
| 0.064 | 0.003 | 0.064 | Thyroid hormone alpha agonist | 0.016 0.012 CID_154699960 | ||
| 0.078 | 0.017 | 0.078 | Sphingosine kinase inhibitor | |||
| 0.081 | 0.02 | 0.095 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.095 0.015 CID_154699960 | CID_154699960 | |
| 0.1 | 0.039 | 0.197 | Topoisomerase II alpha inhibitor | 0.197 0.015 CID_154699960 | CID_154699960 | |
| 0.105 | 0.044 | 0.105 | Calcium antagonist | |||
| 0.084 | 0.024 | 0.084 | Beta adrenoreceptor antagonist | |||
| 0.104 | 0.044 | 0.15 | Phosphodiesterase 6D inhibitor | 0.15 0.01 CID_154699960 | CID_154699960 | |
| 0.111 | 0.052 | 0.19 | Xanthine oxidase inhibitor | 0.19 0.022 CID_154699960 | CID_154699960 | |
| 0.071 | 0.012 | 0.108 | Glucose-6-phosphate isomerase inhibitor | 0.108 0.004 CID_154699960 | CID_154699960 | |
| 0.072 | 0.012 | 0.072 | Pregnane X receptor antagonist | |||
| 0.069 | 0.01 | 0.069 | Oxytocin agonist | |||
| 0.072 | 0.014 | 0.072 | NMDA receptor subunit 3A antagonist | |||
| 0.089 | 0.031 | 0.089 | Vanilloid 1 antagonist | |||
| 0.063 | 0.004 | 0.063 | Cholesterol ester transfer protein antagonist | |||
| 0.068 | 0.011 | 0.068 | Glutamate (mGluR4) antagonist | |||
| 0.065 | 0.007 | 0.065 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.07 | 0.012 | 0.07 | Adenylate cyclase 1 inhibitor | |||
| 0.097 | 0.04 | 0.097 | GABA A receptor agonist | |||
| 0.088 | 0.031 | 0.088 | Amidase inhibitor | |||
| 0.061 | 0.005 | 0.146 | Sodium/glucose cotransporter 2 inhibitor | 0.146 0.001 CID_154699960 | CID_154699960 | |
| 0.096 | 0.039 | 0.096 | Opioid kappa receptor antagonist | |||
| 0.109 | 0.053 | 0.109 | Bronchodilator | |||
| 0.111 | 0.055 | 0.111 | MAO B inhibitor | |||
| 0.071 | 0.015 | 0.071 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.088 | 0.034 | 0.088 | Opioid delta receptor antagonist | |||
| 0.06 | 0.005 | 0.06 | Free fatty acid receptor 1 antagonist | |||
| 0.057 | 0.004 | 0.057 | Retinoid X alpha receptor antagonist | |||
| 0.064 | 0.011 | 0.064 | Glutamate (mGluR group III) antagonist | |||
| 0.057 | 0.005 | 0.057 | Vanilloid 3 antagonist | |||
| 0.064 | 0.012 | 0.064 | AICAR transformylase inhibitor | |||
| 0.061 | 0.01 | 0.061 | AMPA 4 receptor antagonist | |||
| 0.088 | 0.036 | 0.088 | Opioid mu receptor antagonist | |||
| 0.07 | 0.018 | 0.07 | Epithelial sodium channel blocker | |||
| 0.055 | 0.005 | 0.055 | Estrogen-related receptor beta antagonist | |||
| 0.111 | 0.061 | 0.111 | Protein kinase C gamma inhibitor | |||
| 0.064 | 0.015 | 0.064 | 5-Alpha-reductase inhibitor | |||
| 0.081 | 0.031 | 0.081 | Leukotriene antagonist | 0.076 0.035 CID_154699960 | ||
| 0.098 | 0.048 | 0.098 | Histamine N-methyltransferase inhibitor | |||
| 0.067 | 0.018 | 0.067 | Beta 2 adrenoreceptor antagonist | |||
| 0.051 | 0.003 | 0.051 | Estrogen-related receptor gamma agonist | |||
| 0.053 | 0.005 | 0.19 | Sodium/glucose cotransporter inhibitor | 0.19 0.002 CID_154699960 | CID_154699960 | |
| 0.053 | 0.005 | 0.053 | CXC chemokine 2 receptor antagonist | |||
| 0.106 | 0.058 | 0.106 | Gastric antisecretory | |||
| 0.081 | 0.033 | 0.081 | Potassium channel (Tandem pore domain) blocker | |||
| 0.109 | 0.062 | 0.109 | Falcipain 3 inhibitor | |||
| 0.076 | 0.03 | 0.076 | Aryl hydrocarbon receptor antagonist | |||
| 0.064 | 0.018 | 0.064 | CD45 antagonist | |||
| 0.058 | 0.012 | 0.058 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.05 | 0.004 | 0.05 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.05 | 0.005 | 0.05 | Glutamate (mGluR3) agonist | |||
| 0.055 | 0.01 | 0.055 | Glutamate (mGluR3) antagonist | |||
| 0.081 | 0.037 | 0.081 | HIV-1 integrase inhibitor | |||
| 0.056 | 0.012 | 0.056 | Nicotinic acid receptor 2 agonist | |||
| 0.07 | 0.026 | 0.07 | Beta 1 adrenoreceptor antagonist | |||
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | |||
| 0.065 | 0.022 | 0.065 | Thromboxane synthase inhibitor | |||
| 0.056 | 0.013 | 0.056 | Alpha 1d adrenoreceptor agonist | |||
| 0.073 | 0.03 | 0.073 | Plasminogen activator inhibitor | |||
| 0.083 | 0.04 | 0.083 | Lipase inhibitor | |||
| 0.057 | 0.014 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.007 CID_154699960 | CID_154699960 | |
| 0.067 | 0.025 | 0.067 | Cannabinoid CB2 receptor antagonist | |||
| 0.081 | 0.039 | 0.081 | Vanilloid 4 agonist | |||
| 0.064 | 0.022 | 0.159 | Alpha-mannosidase inhibitor | 0.159 0.004 CID_154699960 | CID_154699960 | |
| 0.114 | 0.072 | 0.273 | Topoisomerase II inhibitor | 0.273 0.021 CID_154699960 | CID_154699960 | |
| 0.146 | 0.105 | 0.146 | Tumour necrosis factor antagonist | |||
| 0.052 | 0.01 | 0.052 | Delayed rectifier potassium channel blocker | |||
| 0.068 | 0.027 | 0.068 | Thromboxane antagonist | |||
| 0.044 | 0.003 | 0.044 | Thyroid hormone beta agonist | |||
| 0.069 | 0.029 | 0.069 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.071 | 0.031 | 0.071 | Xanthine dehydrogenase inhibitor | |||
| 0.07 | 0.03 | 0.07 | Transcription factor RelA inhibitor | |||
| 0.05 | 0.01 | 0.05 | Liver X receptor beta agonist | |||
| 0.099 | 0.06 | 0.099 | Sphingomyelinase inhibitor | 0.09 0.072 CID_154699960 | ||
| 0.048 | 0.009 | 0.048 | Melatonin receptor 1A agonist | |||
| 0.084 | 0.045 | 0.084 | CYP2A6 inhibitor | |||
| 0.042 | 0.003 | 0.042 | Nicotinic acid receptor 1 antagonist | |||
| 0.063 | 0.025 | 0.063 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.043 | 0.004 | 0.043 | Nicotinic acid receptor 2 antagonist | |||
| 0.088 | 0.05 | 0.088 | Inducible nitric-oxide synthase inhibitor | |||
| 0.047 | 0.009 | 0.047 | HMG CoA reductase inhibitor | 0.039 0.016 CID_154699960 | ||
| 0.06 | 0.022 | 0.06 | Topoisomerase II beta inhibitor | 0.045 0.041 CID_154699960 | ||
| 0.111 | 0.073 | 0.415 | Cell adhesion inhibitor | 0.415 0.005 CID_154699960 | CID_154699960 | |
| 0.046 | 0.009 | 0.046 | Complement C5a chemotactic receptor antagonist | |||
| 0.053 | 0.017 | 0.053 | GABA B receptor antagonist | |||
| 0.063 | 0.026 | 0.063 | Thromboxane A2 antagonist | |||
| 0.047 | 0.011 | 0.047 | AMPA receptor agonist | |||
| 0.049 | 0.013 | 0.049 | Glutamate (mGluR8) agonist | |||
| 0.054 | 0.018 | 0.054 | Histamine H2 receptor agonist | |||
| 0.056 | 0.02 | 0.056 | Leukocyte elastase inhibitor | |||
| 0.092 | 0.056 | 0.092 | Phosphodiesterase I inhibitor | |||
| 0.169 | 0.133 | 0.373 | Vasodilator | 0.373 0.028 CID_154699960 | CID_154699960 | |
| 0.043 | 0.008 | 0.043 | Liver X receptor alpha antagonist | |||
| 0.083 | 0.048 | 0.109 | Interferon agonist | 0.109 0.022 CID_154699960 | CID_154699960 | |
| 0.077 | 0.042 | 0.077 | Prostaglandin-E synthase inhibitor | |||
| 0.063 | 0.028 | 0.063 | Alpha tubulin antagonist | |||
| 0.049 | 0.015 | 0.049 | Farnesoid X receptor agonist | |||
| 0.038 | 0.005 | 0.038 | ICAM 1 antagonist | |||
| 0.113 | 0.08 | 0.113 | MAP kinase kinase inhibitor | |||
| 0.158 | 0.125 | 0.158 | Growth factor agonist | |||
| 0.044 | 0.012 | 0.044 | Liver X receptor antagonist | |||
| 0.069 | 0.036 | 0.089 | Interferon inducer | 0.089 0.017 CID_154699960 | CID_154699960 | |
| 0.036 | 0.003 | 0.036 | Retinoid X beta receptor antagonist | |||
| 0.037 | 0.005 | 0.037 | Retinoid X gamma receptor antagonist | |||
| 0.047 | 0.015 | 0.047 | Fumarate hydratase inhibitor | 0.035 0.023 CID_154699960 | ||
| 0.064 | 0.032 | 0.064 | Carbonic anhydrase VB inhibitor | |||
| 0.043 | 0.012 | 0.043 | Catechol O-methyltransferase inhibitor | |||
| 0.036 | 0.005 | 0.059 | Vanilloid 2 agonist | 0.059 0.002 CID_154699960 | CID_154699960 | |
| 0.053 | 0.022 | 0.053 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.063 | 0.033 | 0.063 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.071 | 0.041 | 0.071 | Exportin-1 inhibitor | |||
| 0.061 | 0.031 | 0.101 | Aldose reductase inhibitor | 0.101 0.018 CID_154699960 | CID_154699960 | |
| 0.034 | 0.004 | 0.078 | Ileal bile acid transport inhibitor | 0.078 0.002 CID_154699960 | CID_154699960 | |
| 0.04 | 0.01 | 0.04 | Lysine carboxypeptidase inhibitor | |||
| 0.041 | 0.011 | 0.041 | Cyclophilin A inhibitor | |||
| 0.079 | 0.049 | 0.079 | Analgesic, opioid | |||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | |||
| 0.064 | 0.034 | 0.064 | Ribonucleotide reductase inhibitor | |||
| 0.048 | 0.019 | 0.048 | Sphingosine kinase 1 inhibitor | |||
| 0.049 | 0.02 | 0.049 | Beta adrenoreceptor agonist | |||
| 0.066 | 0.037 | 0.066 | Cyclin B1 inhibitor | |||
| 0.047 | 0.018 | 0.047 | TRPM8 blocker | |||
| 0.072 | 0.043 | 0.072 | Protein kinase C beta inhibitor | |||
| 0.052 | 0.023 | 0.167 | Mannosidase inhibitor | 0.167 0.004 CID_154699960 | CID_154699960 | |
| 0.036 | 0.008 | 0.036 | Prostaglandin H2 antagonist | |||
| 0.133 | 0.105 | 0.133 | MAP kinase kinase 4 inhibitor | |||
| 0.058 | 0.03 | 0.088 | Leukotriene B4 antagonist | 0.088 0.013 CID_154699960 | CID_154699960 | |
| 0.037 | 0.009 | 0.037 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.075 | 0.047 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.055 | 0.028 | 0.055 | Bombesin 2 receptor antagonist | |||
| 0.089 | 0.062 | 0.089 | Potassium channel activator | |||
| 0.059 | 0.031 | 0.059 | Leukotriene C antagonist | |||
| 0.064 | 0.037 | 0.064 | Phosphodiesterase 1B inhibitor | |||
| 0.044 | 0.017 | 0.044 | CF transmembrane conductance regulator antagonist | |||
| 0.067 | 0.04 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.059 | 0.033 | 0.059 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.046 | 0.02 | 0.046 | Dihydropteroate synthase inhibitor | |||
| 0.11 | 0.085 | 0.11 | Nav1.3 sodium channel blocker | |||
| 0.032 | 0.006 | 0.032 | Imidazoline I1 receptor antagonist | |||
| 0.044 | 0.018 | 0.044 | Bombesin 1 receptor antagonist | |||
| 0.189 | 0.164 | 0.189 | Prostaglandin dehydrogenase inhibitor | |||
| 0.056 | 0.031 | 0.056 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.03 | 0.005 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.02 0.016 CID_154699960 | ||
| 0.127 | 0.102 | 0.127 | Thiol protease inhibitor | |||
| 0.064 | 0.039 | 0.064 | Histone deacetylase SIRT3 inhibitor | |||
| 0.042 | 0.018 | 0.042 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.065 | 0.041 | 0.065 | NMDA receptor agonist | |||
| 0.124 | 0.1 | 0.284 | Diuretic | 0.284 0.025 CID_154699960 | CID_154699960 | |
| 0.031 | 0.008 | 0.031 | Prostaglandin F2 alpha agonist | |||
| 0.054 | 0.031 | 0.114 | Glucose-6-phosphate translocase inhibitor | 0.114 0.005 CID_154699960 | CID_154699960 | |
| 0.044 | 0.021 | 0.044 | GABA uptake inhibitor | |||
| 0.046 | 0.024 | 0.046 | Dihydrofolate reductase inhibitor | |||
| 0.117 | 0.095 | 0.117 | Histone deacetylase SIRT1 inhibitor | |||
| 0.057 | 0.035 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_154699960 | CID_154699960 | |
| 0.055 | 0.033 | 0.206 | Heparanase inhibitor | 0.206 0.002 CID_154699960 | CID_154699960 | |
| 0.125 | 0.104 | 0.377 | Thrombolytic | 0.377 0.013 CID_154699960 | CID_154699960 | |
| 0.035 | 0.014 | 0.052 | Uridine phosphorylase inhibitor | 0.052 0.008 CID_154699960 | CID_154699960 | |
| 0.052 | 0.031 | 0.061 | Factor III inhibitor | 0.061 0.017 CID_154699960 | CID_154699960 | |
| 0.112 | 0.091 | 0.112 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.027 | 0.007 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 CID_154699960 | ||
| 0.06 | 0.04 | 0.06 | Carbonic anhydrase stimulant | |||
| 0.068 | 0.048 | 0.068 | Cyclin B3 inhibitor | |||
| 0.049 | 0.029 | 0.049 | Opioid mu receptor agonist | |||
| 0.046 | 0.026 | 0.046 | Histamine H1 receptor agonist | |||
| 0.059 | 0.04 | 0.059 | Cyclin A1 inhibitor | |||
| 0.094 | 0.075 | 0.254 | Topoisomerase I inhibitor | 0.254 0.016 CID_154699960 | CID_154699960 | |
| 0.046 | 0.027 | 0.046 | Liver X receptor agonist | |||
| 0.027 | 0.008 | 0.027 | Retinoic acid alpha receptor antagonist | |||
| 0.055 | 0.036 | 0.055 | DNA helicase inhibitor | |||
| 0.046 | 0.027 | 0.046 | Carbonic anhydrase IV inhibitor | |||
| 0.032 | 0.014 | 0.032 | LFA antagonist | |||
| 0.067 | 0.049 | 0.067 | Carbonic anhydrase VA inhibitor | |||
| 0.07 | 0.052 | 0.07 | Calcium channel L-type blocker | |||
| 0.059 | 0.041 | 0.059 | Ca(v)3.2 blocker | |||
| 0.054 | 0.036 | 0.054 | Ornithine carbamoyltransferase inhibitor | |||
| 0.064 | 0.046 | 0.064 | Dopamine D1 antagonist | |||
| 0.023 | 0.006 | 0.037 | Antibiotic Anthracycline-like | 0.037 0.003 CID_154699960 | CID_154699960 | |
| 0.058 | 0.041 | 0.075 | Lipocortins synthesis agonist | 0.075 0.017 CID_154699960 | CID_154699960 | |
| 0.037 | 0.02 | 0.037 | Purinergic P2X3 antagonist | |||
| 0.059 | 0.043 | 0.059 | Phosphodiesterase 1A inhibitor | |||
| 0.022 | 0.006 | 0.031 | Telomerase stimulant | 0.031 0.003 CID_154699960 | CID_154699960 | |
| 0.024 | 0.008 | 0.024 | Retinoic acid receptor antagonist | |||
| 0.081 | 0.065 | 0.081 | Myeloperoxidase inhibitor | |||
| 0.037 | 0.022 | 0.037 | Phosphoglycerate kinase inhibitor | |||
| 0.056 | 0.041 | 0.056 | Fatty acid synthase inhibitor | |||
| 0.026 | 0.011 | 0.033 | Dopamine D1 agonist | 0.033 0.007 CID_154699960 | CID_154699960 | |
| 0.025 | 0.01 | 0.025 | Vitamin D receptor antagonist | 0.023 0.013 CID_154699960 | ||
| 0.054 | 0.039 | 0.054 | GABA receptor antagonist | |||
| 0.025 | 0.012 | 0.025 | Glutamate (mGluR1a) agonist | |||
| 0.019 | 0.005 | 0.019 | Integrin alphaLbeta2 antagonist | |||
| 0.063 | 0.05 | 0.063 | Carbonic anhydrase V inhibitor | |||
| 0.035 | 0.021 | 0.035 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.102 | 0.089 | 0.102 | Acetylcholine muscarinic antagonist | |||
| 0.082 | 0.069 | 0.087 | Interleukin 5 antagonist | 0.087 0.059 CID_154699960 | CID_154699960 | |
| 0.03 | 0.017 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.116 | 0.102 | 0.116 | Neurotrophic factor | 0.112 0.109 CID_154699960 | ||
| 0.035 | 0.022 | 0.035 | Calcitonin receptor agonist | |||
| 0.053 | 0.041 | 0.053 | Cyclin B inhibitor | |||
| 0.049 | 0.037 | 0.049 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.067 | 0.055 | 0.067 | Secretase beta inhibitor | |||
| 0.112 | 0.1 | 0.112 | Interleukin 1 antagonist | |||
| 0.054 | 0.042 | 0.054 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.017 | 0.005 | 0.017 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.051 | 0.04 | 0.051 | Elastase inhibitor | |||
| 0.017 | 0.006 | 0.017 | Integrin beta6 antagonist | |||
| 0.044 | 0.033 | 0.044 | Oleamide hydrolase inhibitor | |||
| 0.044 | 0.033 | 0.044 | Neurotensin receptor antagonist | |||
| 0.023 | 0.012 | 0.023 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.024 | 0.014 | 0.024 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.018 | 0.008 | 0.018 | NMDA receptor phencyclidine site antagonist | |||
| 0.02 | 0.01 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.014 | 0.005 | 0.014 | Imidazoline I2 receptor antagonist | |||
| 0.064 | 0.054 | 0.064 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.022 | 0.012 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.046 | 0.037 | 0.046 | Bombesin antagonist | |||
| 0.038 | 0.029 | 0.038 | Vascular adhesion protein 1 inhibitor | |||
| 0.025 | 0.016 | 0.025 | Glutamate (mGluR1) agonist | |||
| 0.018 | 0.009 | 0.018 | Vitamin D receptor agonist | 0.016 0.012 CID_154699960 | ||
| 0.023 | 0.015 | 0.023 | CYP24 inhibitor | |||
| 0.032 | 0.024 | 0.032 | Carboxypeptidase B inhibitor | |||
| 0.073 | 0.065 | 0.26 | Cell adhesion molecule inhibitor | 0.26 0.006 CID_154699960 | CID_154699960 | |
| 0.056 | 0.048 | 0.056 | Cathepsin E inhibitor | |||
| 0.02 | 0.013 | 0.02 | 5-Alpha-reductase 2 inhibitor | |||
| 0.057 | 0.049 | 0.057 | Bcl-xL inhibitor | |||
| 0.023 | 0.016 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.052 | 0.044 | 0.052 | Cyclin B2 inhibitor | |||
| 0.033 | 0.026 | 0.033 | RNA-directed RNA polymerase inhibitor | |||
| 0.038 | 0.031 | 0.038 | Leukotriene C4 antagonist | |||
| 0.071 | 0.064 | 0.256 | Antineoplastic antibiotic | 0.256 0.014 CID_154699960 | CID_154699960 | |
| 0.036 | 0.029 | 0.036 | Diamine oxidase inhibitor | |||
| 0.108 | 0.101 | 0.2 | DNA repair enzyme inhibitor | 0.2 0.009 CID_154699960 | CID_154699960 | |
| 0.048 | 0.042 | 0.048 | Opioid agonist | |||
| 0.03 | 0.023 | 0.03 | HCV NS5B polymerase inhibitor | |||
| 0.037 | 0.031 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.012 | 0.006 | 0.012 | Thromboxane agonist | |||
| 0.051 | 0.046 | 0.051 | Beta tubulin antagonist | |||
| 0.038 | 0.032 | 0.038 | CDK5/p25 inhibitor | |||
| 0.217 | 0.212 | 0.217 | Transcription factor inhibitor | |||
| 0.07 | 0.065 | 0.07 | Metalloproteinase-2 inhibitor | |||
| 0.046 | 0.041 | 0.059 | Cytokine production stimulant | 0.059 0.014 CID_154699960 | CID_154699960 | |
| 0.049 | 0.044 | 0.049 | Alpha 1L adrenoreceptor antagonist | |||
| 0.034 | 0.029 | 0.034 | Kinesin-like protein 1 inhibitor | |||
| 0.034 | 0.029 | 0.034 | Kinesin antagonist | |||
| 0.028 | 0.023 | 0.028 | Vasopressin 1A agonist | |||
| 0.042 | 0.037 | 0.042 | Urokinase inhibitor | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.027 | 0.023 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 CID_154699960 | CID_154699960 | |
| 0.122 | 0.118 | 0.122 | Growth hormone agonist | |||
| 0.059 | 0.055 | 0.059 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.045 | 0.041 | 0.045 | Potassium channel (Inward rectifier) blocker | |||
| 0.04 | 0.036 | 0.04 | Purinergic P2Y antagonist | |||
| 0.017 | 0.013 | 0.017 | Free fatty acid receptor 1 agonist | |||
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.033 | 0.03 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.03 CID_154699960 | ||
| 0.078 | 0.075 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.059 | 0.056 | 0.059 | Acetylcholine M5 receptor agonist | |||
| 0.007 | 0.004 | 0.007 | Integrin alpha5beta6 antagonist | |||
| 0.021 | 0.019 | 0.021 | Beta 1 adrenoreceptor agonist | |||
| 0.044 | 0.041 | 0.071 | Carbonic anhydrase XIV inhibitor | 0.071 0.02 CID_154699960 | CID_154699960 | |
| 0.033 | 0.03 | 0.033 | Histone deacetylase 7 inhibitor | |||
| 0.032 | 0.03 | 0.063 | Arginase inhibitor | 0.063 0.009 CID_154699960 | CID_154699960 | |
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.011 | 0.009 | 0.011 | Retinoic acid receptor gamma antagonist | |||
| 0.011 | 0.01 | 0.011 | Integrin beta2 antagonist | |||
| 0.024 | 0.023 | 0.024 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.025 | 0.024 | 0.025 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.131 | 0.13 | 0.454 | Platelet adhesion inhibitor | 0.454 0.008 CID_154699960 | CID_154699960 | |
| 0.048 | 0.047 | 0.048 | Vanilloid 2 antagonist | |||
| 0.041 | 0.04 | 0.041 | Heme oxygenase inhibitor | |||
| 0.036 | 0.035 | 0.036 | Histone deacetylase 9 inhibitor | |||
| 0.013 | 0.012 | 0.013 | Egl nine homolog 1 inhibitor | |||
| 0.011 | 0.01 | 0.011 | Retinoic acid beta receptor antagonist | |||
| 0.044 | 0.047 | 0.121 | Factor IXa inhibitor | 0.121 0.005 CID_154699960 | CID_154699960 | |
| 0.016 | 0.029 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.016 CID_154699960 | CID_154699960 | |
| 0.007 | 0.022 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CID_154699960 | CID_154699960 | |
| 0.064 | 0.08 | 0.071 | Phosphodiesterase VI inhibitor | 0.071 0.06 CID_154699960 | CID_154699960 | |
| 0.053 | 0.074 | 0.115 | Neuraminidase (influenza) inhibitor | 0.115 0.013 CID_154699960 | CID_154699960 | |
| 0.048 | 0.073 | 0.086 | Nitric oxide donor | 0.086 0.017 CID_154699960 | CID_154699960 | |
| 0.028 | 0.06 | 0.063 | Carbonic anhydrase XII inhibitor | 0.063 0.031 CID_154699960 | CID_154699960 | |
| 0.187 | 0.223 | 0.34 | Antiobesity | 0.34 0.092 CID_154699960 | CID_154699960 | |
| 0.045 | 0.083 | 0.063 | Transcription factor AP-1 inhibitor | 0.063 0.04 CID_154699960 | CID_154699960 | |
| 0.038 | 0.076 | 0.101 | Neuraminidase inhibitor | 0.101 0.015 CID_154699960 | CID_154699960 | |
| 0.031 | 0.072 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.063 0.01 CID_154699960 | CID_154699960 | |
| 0.011 | 0.054 | 0.021 | Corticosteroid-like | 0.021 0.016 CID_154699960 | CID_154699960 | |
| 0.114 | 0.158 | 0.153 | CC chemokine 6 receptor antagonist | 0.153 0.019 CID_154699960 | CID_154699960 | |
| 0.003 | 0.049 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_154699960 | CID_154699960 | |
| 0.019 | 0.067 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 CID_154699960 | CID_154699960 | |
| 0.029 | 0.083 | 0.132 | Protein 50S ribosomal subunit inhibitor | 0.132 0.008 CID_154699960 | CID_154699960 | |
| 0.023 | 0.078 | 0.083 | Phosphorylase inhibitor | 0.083 0.016 CID_154699960 | CID_154699960 | |
| 0.159 | 0.219 | 0.548 | Immunomodulator | 0.548 0.017 CID_154699960 | CID_154699960 | |
| 0.028 | 0.092 | 0.054 | Microtubule stabilization | 0.054 0.023 CID_154699960 | CID_154699960 | |
| 0.009 | 0.074 | 0.053 | Squalene synthetase inhibitor | 0.053 0.014 CID_154699960 | CID_154699960 | |
| 0.03 | 0.103 | 0.418 | Selectin antagonist | 0.418 0.003 CID_154699960 | CID_154699960 | |
| 0.041 | 0.129 | 0.1 | Histone deacetylase stimulant | 0.1 0.028 CID_154699960 | CID_154699960 | |
| 0.041 | 0.129 | 0.1 | Histone deacetylase SIRT1 stimulant | 0.1 0.028 CID_154699960 | CID_154699960 | |
| 0.109 | 0.204 | 0.376 | Platelet antagonist | 0.376 0.032 CID_154699960 | CID_154699960 | |
| 0.011 | 0.108 | 0.065 | Protein 30S ribosomal subunit inhibitor | 0.065 0.005 CID_154699960 | CID_154699960 | |
| 0.063 | 0.177 | 0.102 | T cell inhibitor | 0.102 0.023 CID_154699960 | CID_154699960 | |
| 0.055 | 0.181 | 0.161 | Transcription factor NF kappa B stimulant | 0.161 0.014 CID_154699960 | CID_154699960 | |
| 0.018 | 0.177 | 0.086 | Antibiotic Aminoglycoside-like | 0.086 0.004 CID_154699960 | CID_154699960 | |
| 0.04 | 0.219 | 0.134 | DNA intercalator | 0.134 0.05 CID_154699960 | CID_154699960 | |
| 0.043 | 0.26 | 0.102 | Multidrug resistance-associated protein 1 inhibitor | 0.102 0.075 CID_154699960 | CID_154699960 | |
| 0.069 | 0.328 | 0.435 | Tumour necrosis factor alpha release inhibitor | 0.435 0.021 CID_154699960 | CID_154699960 | |
| 0.035 | 0.336 | 0.084 | Falcipain 2 inhibitor | 0.084 0.065 CID_154699960 | CID_154699960 | |
| 0.035 | 0.339 | 0.086 | Falcipain inhibitor | 0.086 0.066 CID_154699960 | CID_154699960 | |
| 0.005 | 0.379 | 0.025 | Motilin receptor agonist | 0.025 0.013 CID_154699960 | CID_154699960 | |
| 0.005 | 0.412 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.015 CID_154699960 | CID_154699960 | |
| 0.056 | 0.467 | 0.252 | Angiogenesis inhibitor | 0.252 0.121 CID_154699960 | CID_154699960 | |
| 0.028 | 0.456 | 0.265 | Anticoagulant | 0.265 0.035 CID_154699960 | CID_154699960 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |